News
Brian Armstrong’s NewLimit raises a $130M Series B, laying out road map for anti-aging drugs
NewLimit raises $130M Series B led by Kleiner Perkins to advance epigenetic reprogramming research for liver disease ...
Vertex paused an early-stage trial of its inhaled treatment for cystic fibrosis that came from a partnership with Moderna.
House and Senate lawmakers from both parties are working with the Trump administration on proposals that would use drug ...
The FDA on Tuesday said it is planning on doing more surprise inspections of foreign factories, a day after Trump signed an ...
Attorneys general from 19 states and Washington, DC have filed a lawsuit against the federal government alleging that its ...
Plus, news about Atara Biotherapeutics, Immutep, bluebird bio, OSE Immunotherapeutics, Mersana Therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results